Euclidean Capital »

Surrozen shares owned by Euclidean Capital

Quarter-by-quarter ownership of Surrozen (SRZN) shares owned by Euclidean Capital from 13F filings

Historical chart of Euclidean Capital investment in Surrozen

Tip: Access up to 7 years of quarterly data

All positions including Surrozen held by Euclidean Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Surrozen by Euclidean Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $960k 88k 10.95
2024-03-31 $1.4M 88k 15.71
2023-12-31 $824k 88k 9.40

More positions owned by Euclidean Capital

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Msci India Etf (INDA)
Foghorn Therapeutics (FHTX)
Oric Pharmaceuticals (ORIC)
Alector (ALEC)
Pmv Pharmaceuticals (PMVP)
23andme Holding Class A Com (ME)
Tenaya Therapeutics (TNYA)
Rapt Therapeutics (RAPT)
Surrozen Com New (SRZN)
Surrozen *w Exp 08/01/203 (SRZNW)

View all positions for Euclidean Capital

Top funds holding Surrozen

RA Capital Management
Alyeska Investment Group
Armistice Capital
Nantahala Capital Management
Stempoint Capital
Euclidean Capital
Stonepine Capital Management
CVI Holdings
Vanguard Group
Arrowpoint Asset Management
Board of Trustees of The Leland Stanford Junior University
Morgan Stanley
Geode Capital Management
Renaissance Technologies
BlackRock

View all funds holding Surrozen